Morria Biopharmaceuticals
Celsus Therapeutics is a drug development company focusing on novel anti-inflammatory;first-in-class synthetic drugs.
Total raised
€13M
€13,440,600
Funding rounds
3
Investors
0
distinct backers
Active since
2012-11
latest 2013-09
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood13
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ 19y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2013-10-01 | Other | €11M | — | View deal → |
| 2013-02-01 | Other | €838k | — | View deal → |
| 2012-12-01 | Other | €1.4M | — | View deal → |